Financhill
Back

Lyra Therapeutics Stock Predictions

Lyra Therapeutics Stock Forecast

  • Over the next 52 weeks, Lyra Therapeutics has on average historically fallen by 45.1% based on the past 5 years of stock performance.
  • Lyra Therapeutics has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Lyra Therapeutics Stock Undervalued?
    The current Lyra Therapeutics [LYRA] share price is $10.68. The Score for LYRA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • LYRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Lyra Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Lyra Therapeutics has on average historically fallen by 45.1% based on the past 5 years of stock performance.

Lyra Therapeutics Stock Rating

Sell
29
Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics overpriced?

  • Lyra Therapeutics has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Lyra Therapeutics Stock Price History

Is LYRA stock going to rise?

  • The current trend is moderately bearish and LYRA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
lyratherapeutics.com

52-Week Data

52-Week High:
37.50
52-Week Low:
3.81

Prediction Charts

Market Cap:
14.2M
Price in USD:
10.68
Volume:
117.6K
Beta:
-0.01

Technical Analysis

SMA50:
8.14
SMA100:
8.48
SMA200:
9.95
52-Wk Change:
-17.47%

Stock Predictions

  • Is Lyra Therapeutics stock public?
    Yes, Lyra Therapeutics is a publicly traded company.
  • What is the Lyra Therapeutics stock quote today?
    The Lyra Therapeutics stock price is 10.68 USD today.
  • How to buy Lyra Therapeutics stock online?
    You can buy Lyra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 5.01 4.93 5.34 4.60
Jun-2 29.01 20.25 37.50 8.65
Jun-3 22.70 27.58 34.00 22.51
Jun-4 25.61 22.82 26.04 22.27
Jun-5 22.25 25.33 27.42 22.22
Jun-6 25.02 24.28 26.50 23.85
Jun-9 22.76 18.42 23.83 18.10
Jun-10 17.53 15.50 19.45 15.33
Jun-11 14.88 13.50 14.91 12.53
Jun-12 13.33 11.85 13.50 11.51
Jun-13 11.49 11.34 12.50 10.98
Jun-16 11.18 11.33 12.17 10.56
Jun-17 11.33 10.28 11.64 10.27
Jun-18 10.21 10.68 11.06 9.81

Lyra Therapeutics Earnings

Lyra Therapeutics Earnings Report: Per Share Lyra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Lyra Therapeutics Forecast Revenue Growth

Lyra Therapeutics Stock Analysis: Historical quarterly revenues per share for Lyra Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

* Lyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.